Proteomic profiling reveals CDK6 upregulation as a targetable resistance mechanism for lenalidomide in multiple myeloma.

The complementary nature of the different datasets was also reflected by highly significant single sample gene set enrichment analysis (ssGSEA) signatures observed in the phosphoproteomic data and, to a lesser extent, in the proteomic data (Supplementary Fig. 3D ).

also in 132,142 other papers